Skip to main content
Equibles
VCYT logo

VCYT · Veracyte, Inc. · Metrics

Track VCYT — free

Use VCYT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research VCYT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$50.29 +1.29 (+2.63%) Earnings today Q2 2026 earnings call transcript
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$4.04B
Shares
80.39M
Volume · Nov 3 1.08M Avg daily vol (3M) 1.3M

VCYT metrics

103 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$50.29
Market cap
$4.04B

Price action

20 metrics
Price change (1W)
+1.7%
Price change (30D)
+2.8%
Price change (3M)
+9.3%
Price change (6M)
+46.5%
Price change (YTD)
+16.4%
Price change (1Y)
+35.8%
Trailing year
Price change (5Y)
-6.7%
52-week high
$60.49
52-week low
$30.01
Change from 52-week high
-19.0%
Change from 52-week low
+63.3%
Annualized volatility
66.0%
Annualized volatility (3M)
53.5%
Beta
1.6
RSI (14D)
57.4
Price vs SMA 50
+10.0%
Price vs SMA 200
+14.3%
Avg volume (3M)
1.31M
Relative volume
0.9
Average dollar volume
$58.13M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
80.39M

Valuation

12 metrics
P / E (TTM)
35.0
Trailing earnings · reciprocal yield 2.9%
PEG ratio
0.2
EV / revenue
6.5×
reciprocal yield 15.3%
EV / EBITDA
29.0×
reciprocal yield 3.5%
EV / EBIT
34.7×
reciprocal yield 2.9%
P / sales
7.1×
reciprocal yield 14.2%
P / book
2.9
reciprocal yield 35.0%
FCF yield
4.2%
TTM · current market cap
Buyback yield
—
P / FCF
23.9
reciprocal yield 4.2%
P / operating cash flow
22.2
reciprocal yield 4.5%
Earnings yield
2.9%

Historical valuation

8 metrics
P / E historical average (3Y)
72.1×
reciprocal yield 1.4%
P / E historical average (5Y)
72.1×
reciprocal yield 1.4%
EV / revenue historical average (3Y)
5.4×
reciprocal yield 18.4%
EV / revenue historical average (5Y)
6.8×
reciprocal yield 14.6%
EV / EBIT historical average (3Y)
91.8×
reciprocal yield 1.1%
EV / EBIT historical average (5Y)
91.8×
reciprocal yield 1.1%
EV / EBITDA historical average (3Y)
45.9×
reciprocal yield 2.2%
EV / EBITDA historical average (5Y)
45.9×
reciprocal yield 2.2%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-04
Last earnings
2026-07-30

Profitability

9 metrics
Gross margin
71.7%
Operating margin
18.8%
Trailing 12 months
Net margin
20.4%
Gross profit (TTM)
$402.96M
Operating profit (TTM)
$105.77M
Net income (TTM)
$114.48M
Trailing 12 months
Diluted EPS (TTM)
$1.40
FCF margin
29.5%
Effective tax rate
1.3%

Per share

11 metrics
Revenue per diluted share (TTM)
$6.87
Gross profit per diluted share (TTM)
$4.92
Operating profit per diluted share (TTM)
$1.29
EBITDA per diluted share (TTM)
$1.54
Net income per diluted share (TTM)
$1.39
Operating cash flow per diluted share (TTM)
$2.18
Free cash flow per diluted share (TTM)
$2.03
Capital expenditures per diluted share (TTM)
$0.15
R&D per diluted share (TTM)
$1.14
Stock compensation per diluted share (TTM)
$0.59
Book value per share
$16.50

Growth

11 metrics
Revenue growth YoY
+15.5%
Year over year
Net income growth YoY
+174.9%
Revenue (TTM)
$561.90M
Trailing 12 months
EPS growth YoY
+164.5%
Shares change YoY
+4.7%
Year over year · more shares
Revenue CAGR (3Y)
+20.4%
Revenue CAGR (5Y)
+34.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
8.2%
Return on assets
7.7%
Debt / equity
0.0
Current ratio
9.2
EBITDA (TTM)
$126.60M
Free cash flow (TTM)
$165.99M
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
-2.4
Return on invested capital
9.6%
Trailing 12 months
Net cash
$299.52M
Latest balance sheet
Cash & equivalents
$299.52M
Total assets
$1.49B
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$178.38M
Capital expenditures (TTM)
$12.39M
R&D (TTM)
$93.37M
SG&A (TTM)
—
Stock compensation (TTM)
$48.51M
R&D / revenue
16.6%
Stock compensation / revenue
8.6%

Ownership (13F)

9 metrics
13F filers
374
13F filer change QoQ
+36
Institutional ownership
111.1%
Conviction holders (share of 13F filers)
0.5%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-0.2%
Holder tenure
16.3
Price vs estimated holder cost
+68.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
33.9%

Short interest

3 metrics
Short interest
12.2%
Latest settlement · 8.5 days to cover
Days to cover
8.5d
Short-squeeze score
90 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$2.86M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1384101 CUSIP 92337F107 13F (30d) 113 filings 102 filers Visit website Investor relations